Madeleine M. Castellanos, MD, discusses hormones beyond just estrogen and testosterone need to be considered when developing treatment plans for sexual dysfunction, and provides advice for physicians that...
Camillo Ricordi, MD, discusses different versions of a a bioengineered “mini organ” for islet transplantation that that mimics the native pancreas and could eliminate the need for insulin therapy for type 1...
Jeremy Lieb, MD, discusses a test that enables physicians to actively monitor a patient’s prostate cancer and choose less aggressive forms of treatment for less advanced cases, ultimately helping some...
Ralph A. DeFronzo, MD, discusses the utilization of glucagon-like peptide-1 agonists and incorporating evidence-based guidelines into practice when considering the use of incretin-based therapies for type 2...
